Short answer
Gossamer Bio, Inc. (GOSS) filed an 8-K current report with the SEC on August 26, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Series A-1 convertible preferred stock formally established through a Delaware Certificate of Designation filing.
Gossamer Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Series A-1 convertible preferred stock formally established through a Delaware Certificate of Designation filing
- Amendment completed August 24, 2026, alongside the previously announced private placement
- Preferred-stock terms may affect common shareholders through conversion rights and seniority over common equity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Gossamer Bio, Inc. 8-K filings
Get the next GOSS 8-K as it lands
Follow GOSS for push alerts, or ask the research agent what this filing means.